Maternal and Infant Syphilis Prevention Act
Latest Action
Referred to the House Committee on Energy and Commerce.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The Maternal and Infant Syphilis Prevention Act (H.R. 8839) is a bill introduced in the 118th Congress aimed at addressing syphilis infections among pregnant women and infants. Although the official summary and full text of the bill are not available, the title indicates a focus on prevention efforts related to maternal and infant health concerning syphilis. The bill was referred to the House Committee on Energy and Commerce but did not advance further and is currently classified as failed or expired.
H.R. 8839 sought to enhance prevention of syphilis in mothers and infants but did not progress beyond committee referral and has expired without enactment.
- The bill targets prevention of syphilis transmission from mothers to infants.
- It was introduced in the House and referred to the Energy and Commerce Committee.
- The bill did not advance and is now considered failed or expired.
['Pregnant women at risk of syphilis infection', 'Infants potentially exposed to syphilis', 'Public health agencies involved in infectious disease prevention', 'Healthcare providers focusing on maternal and infant health']
['Lack of publicly available full text limits assessment of specific provisions and funding mechanisms', 'Unclear implementation strategies and oversight responsibilities due to missing details', 'Potential costs and resource allocation for prevention programs are not specified']
The bill was introduced during the 118th Congress and referred to the House Committee on Energy and Commerce, which oversees public health legislation. The absence of further legislative action and its current failed or expired status indicate it did not gain sufficient support or priority for advancement during this session.
Hidden impact flags detected: 1
GovScope reviewed 1 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Potential increased awareness and prioritization of maternal and infant syphilis prevention in public health discussions.', "Possible influence on future legislation addressing congenital infectious diseases despite this bill's failure."]
The lack of an official summary and full bill text reduces transparency and public understanding of the bill's specific measures and funding. This limits oversight capabilities and informed evaluation by stakeholders. Tracking the bill's referral to the Energy and Commerce Committee without further action highlights the importance of monitoring committee processes and legislative progression for public health-related bills.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.